EMA Authorised: Memantine Merz (memantine hydrochloride) — Merz Pharmaceuticals GmbH

View source ↗

Summary

EMA authorised Memantine Merz (memantine hydrochloride) for Alzheimer’s disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine Merz (memantine hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Alzheimer Disease. MAH: Merz Pharmaceuticals GmbH. Decision date: 19/06/2025